This post was originally published on this site
Elevance Health announced earnings per share of $0.3 on revenue of $430M. Analysts polled by Investing.com anticipated EPS of $7.74 on revenue of $37.92B.
Elevance Health shares are up 7% from the beginning of the year, still down 6.79% from its 52 week high of $533.68 set on April 21. They are outperforming the S&P 500 which is down 17.4% from the start of the year.
Elevance Health’s report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.55 on revenue of $23.8B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
